The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 08, 2015

Filed:

Jun. 27, 2013
Applicants:

Norbert Gleicher, New York, NY (US);

David H. Barad, Closter, NJ (US);

Dwyn V. Harben, Bryn Mawr, PA (US);

Inventors:

Norbert Gleicher, New York, NY (US);

David H. Barad, Closter, NJ (US);

Dwyn V. Harben, Bryn Mawr, PA (US);

Assignee:

Other;

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A01N 45/00 (2006.01); A61K 31/56 (2006.01); A61K 31/5685 (2006.01); A61K 31/57 (2006.01); A61K 38/24 (2006.01);
U.S. Cl.
CPC ...
A61K 31/5685 (2013.01); A61K 31/57 (2013.01); A61K 38/24 (2013.01);
Abstract

Method of improving ovarian reserve in a human female with diminished ovarian reserve as measured by the female's anti-Müllerian hormone level. The method may include evaluating a first anti-Müllerian hormone level of the female, administering an androgen, such as dehydroepiandrosterone or testosterone, to the female for at least about one month, and then evaluating a second anti-Müllerian hormone level of the female. Change in the anti-Müllerian hormone level is indicative of change in the ovarian reserve, e.g., when the second anti-Müllerian hormone level is greater than the first anti-Müllerian hormone level, the ovarian reserve has improved. The androgen administration may continue until the second anti-Müllerian hormone level is greater than the first anti-Müllerian hormone level by a desired percentage or amount.


Find Patent Forward Citations

Loading…